newron pharmaceuticals spa
(NWRN:SIX Swiss Exchange)
Chief Medical Officer, Oxford Gene Technology IP Limited
|Age||Total Calculated Compensation||This person is connected to 39 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. Robert Holland, also known as Bob, has been the Chief Medical Officer of Oxford Gene Technology IP Limited since September 2013. Dr. Holland serves as Vice President of Global Experimental Medicine at AstraZeneca. Dr. Holland has an impressive clinical track record with over 25 years experience in the pharmaceutical industry, where he has contributed to the development of significant medicines in neuroscience and oncology with combined total annual sales of $8 billion. ...
Via Ludovico Ariosto 21Phone: 39 026 103461
Bresso, Milan 20091
Fax: 39 02 61 03 46 54
Board Members Memberships*
Non-Executive Director and Member of R & D Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|